The Use of Plasminogen Activator Inhibitor-1 Activity As an Early Marker of Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus
Samira Hussam Sibai;
Abstract
Plasminogen activator inhibitor-1 (PAI-1), a45-kDa serine proteinase inhibitor, is the main physiological plasminogen activator inhibitor.
Besides its role in regulating hemostasis, PAI-1 plays a role in several biological processes dependent on plasmin
Besides its role in regulating hemostasis, PAI-1 plays a role in several biological processes dependent on plasmin
Other data
| Title | The Use of Plasminogen Activator Inhibitor-1 Activity As an Early Marker of Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus | Other Titles | استخدام قياس نشاط مثبط منشط البلاسمينوجين-١ كمؤشر مبكر على سوء وظيفة البطانة الوعائية في المرضى المصابين بالداء السكري من النمط الثاني | Authors | Samira Hussam Sibai | Keywords | The Use of Plasminogen Activator Inhibitor-1 Activity As an Early Marker of Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus | Issue Date | 2009 | Description | Plasminogen activator inhibitor-1 (PAI-1), a45-kDa serine proteinase inhibitor, is the main physiological plasminogen activator inhibitor. Besides its role in regulating hemostasis, PAI-1 plays a role in several biological processes dependent on plasmin |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 83284Binder1.pdf | 450.26 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.